{"nctId":"NCT04132050","briefTitle":"A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788","startDateStruct":{"date":"2019-12-24","type":"ACTUAL"},"conditions":["Idiopathic Thrombocytopenic Purpura"],"count":34,"armGroups":[{"label":"R788","type":"EXPERIMENTAL","interventionNames":["Drug: R788"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: R788","Drug: Placebo"]}],"interventions":[{"name":"R788","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Japanese patients\n* Patients diagnosed with idiopathic thrombocytopenic purpura at least 6 months before acquisition of consent\n* Patients with a platelet count averages \\<30000/μL during screening period. Each platelet count should not exceed 35000/μL.\n* Patients who have used and failed or who were intolerant at least 1 typical regimen for the treatment of ITP before informed consent (with or without splenectomy)\n\nExclusion Criteria:\n\n* Patients with thrombocytopenia associated with other disease\n* Patients with autoimmune hemolytic anemia\n* Patients with poorly controlled hypertension\n* Patients with a history or active coagulopathy","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Achievement Rate of Stable Platelet Response","description":"The percentage of subjects who achieved stable platelet response (defined as a platelet count of ≥50000/μL at 4 or more of the 6 visits from Weeks 14 to 24)","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":null},{"groupId":"OG001","value":"0.0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Duration of Platelet Response","description":"Period from the first measurement day on which a platelet count of ≥50000/μL for at least 28 consecutive days was achieved to the first measurement day on which platelet count fell below 50000/μL for at least 28 consecutive days","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"392","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":22},"commonTop":["Diarrhoea","Hypertension","Constipation","Eczema","COVID-19"]}}}